Registro:

Referencias:

• Weigelt, B., Peterse, J.L., van 't Veer, L.J., Breast cancer metastasis: markers and models (2005) Nat Rev Cancer., 5, pp. 591-602
• Caldas, C., Stingl, J., Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis (2007) Nat Rev Cancer., 7, pp. 791-799
• Mayer, I.A., Abramson, V.G., Lehmann, B.D., Pietenpol, J.A., New strategies for triple-negative breast cancer-deciphering the heterogeneity (2014) Clin Cancer Res., 20, pp. 782-790
• Scolz, M., Widlund, P.O., Piazza, S., Bublik, D.R., Reber, S., Peche, L.Y., Ciani, Y., Schneider, C., GTSE1 Is a microtubule plus-end tracking protein that regulates eb1-dependent cell migration (2012) PLoS One., 7
• Utrera, R., Collavin, L., Lazarevic, D., Delia, D., Schneider, C., A novel p53-inducible gene coding for a microtubulelocalized protein with G2-phase-specific expression (1998) EMBO J., 17, pp. 5015-5025
• Collavin, L., Monte, M., Verardo, R., Pfleger, C., Schneider, C., Cell-cycle regulation of the p53-inducible gene B99 (2000) FEBS Lett., 481, pp. 57-62
• Monte, M., Collavin, L., Lazarevic, D., Utrera, R., Dragani, T.A., Schneider, C., Cloning, chromosome mapping and functional characterization of a human homologue of murine Gtse-1 (B99) gene (2000) Gene., 254, pp. 229-236
• Bublik, D.R., Scolz, M., Triolo, G., Monte, M., Schneider, C., Human GTSE-1 regulates p21CIP1/WAF1 stability conferring resistance to paclitaxel treatment (2010) J Biol Chem., 285, pp. 5274-5281
• Subhash, V.V., Tan, S.H., Tan, W.L., Yeo, M.S., Xie, C., Wong, F.Y., Kiat, Z.Y., Jemal, A., GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells (2015) BMC Cancer., 15, p. 550
• Bendre, S., Rondelet, A., Hall, C., Schmidt, N., Lin, Y.C., Brouhard, G.J., Bird, A.W., GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK (2016) J Cell Biol., 215, pp. 631-647
• Lee, J., Sung, C.O., Lee, E.J., Do, I.G., Kim, H.C., Yoon, S.H., Lee, W.Y., Park, Y.S., Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the atm gene (2012) PLoS One., 7
• Zhou, X., Temam, S., Oh, M., Pungpravat, N., Huang, B.L., Mao, L., Wong, D.T., Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma (2006) Neoplasia., 8, pp. 925-932
• Guo, L., Zhang, S., Zhang, B., Chen, W., Li, X., Zhang, W., Zhou, C., Ye, Q., Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells (2016) Cell Biol Toxicol., 32, pp. 263-274
• Tian, W., Yu, J., Tomchick, D.R., Pan, D., Luo, X., Structural and functional analysis of the YAP-binding domain of human TEAD2 (2010) Proc Natl Acad Sci U S A., 107, pp. 7293-7298
• Xiao, J.H., Davidson, I., Matthes, H., Garnier, J.M., Chambon, P., Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1 (1991) Cell., 65, pp. 551-568
• Pobbati, A.V., Hong, W., Emerging roles of TEAD transcription factors and its coactivators in cancers (2013) Cancer Biol Ther., 14, pp. 390-398
• Lamar, J.M., Stern, P., Liu, H., Schindler, J.W., Jiang, Z.G., Hynes, R.O., The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain (2012) Proc Natl Acad Sci U S A., 109
• Zhang, H., Liu, C.Y., Zha, Z.Y., Zhao, B., Yao, J., Zhao, S., Xiong, Y., Guan, K.L., TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition (2009) J Biol Chem., 284, pp. 13355-13362
• Wang, Z., Wu, Y., Wang, H., Zhang, Y., Mei, L., Fang, X., Zhang, X., Zheng, Y., Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility (2014) Proc Natl Acad Sci U S A., 111
• Chen, J., Zhu, F., Weaks, R.L., Biswas, A.K., Guo, R., Li, Y., Johnson, D.G., E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks (2011) Cell Cycle., 10, pp. 1287-1294
• Kel, A.E., Kel-Margoulis, O.V., Farnham, P.J., Bartley, S.M., Wingender, E., Zhang, M.Q., Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors (2001) J Mol Biol., 309, pp. 99-120
• Lazzerini Denchi, E., Helin, K., E2F1 is crucial for E2Fdependent apoptosis (2005) EMBO Rep., 6, pp. 661-668
• Li, F.X., Zhu, J.W., Tessem, J.S., Beilke, J., Varella-Garcia, M., Jensen, J., Hogan, C.J., DeGregori, J., The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss (2003) Proc Natl Acad Sci U S A., 100, pp. 12935-12940
• Luo, W., Li, G., Yi, Z., Nie, Q., Zhang, X., E2F1-miR-20a- 5p/20b-5p auto-regulatory feedback loop involved in myoblast proliferation and differentiation (2016) Sci Rep., 6, p. 27904
• Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., Nevins, J.R., Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis (2001) Mol Cell Biol., 21, pp. 4684-4699
• Müller, H., Bracken, A.P., Vernell, R., Moroni, M.C., Christians, F., Grassilli, E., Prosperini, E., Helin, K., E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis (2001) Genes Dev., 15, pp. 267-285
• Wells, J., Boyd, K.E., Fry, C.J., Bartley, S.M., Farnham, P.J., Target gene specificity of E2F and pocket protein family members in living cells (2000) Mol Cell Biol., 20, pp. 5797-5807
• Martelli, F., Livingston, D.M., Regulation of endogenous E2F1 stability by the retinoblastoma family proteins (1999) Proc Natl Acad Sci U S A., 96, pp. 2858-2863
• Matys, V., Kel-Margoulis, O.V., Fricke, E., Liebich, I., Land, S., Barre-Dirrie, A., Reuter, I., Lewicki-Potapov, B., TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes (2006) Nucleic Acids Res., 34, pp. D108-D110
• Wang, C., Nie, Z., Zhou, Z., Zhang, H., Liu, R., Wu, J., Qin, J., Shi, P., The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1 (2015) Oncotarget., 6, pp. 17685-17697
• Sorrentino, G., Ruggeri, N., Specchia, V., Cordenonsi, M., Mano, M., Dupont, S., Manfrin, A., Del Sal, G., Metabolic control of YAP and TAZ by the mevalonate pathway (2014) Nat Cell Biol., 16, pp. 357-366
• Bischoff, H., Angerbauer, R., Bender, J., Bischoff, E., Faggiotto, A., Petzinna, D., Pfitzner, J., Thomas, G., Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor (1997) Atherosclerosis., 135, pp. 119-130
• Siew, W.C., Chun, J.L., Guo, K., Chee, P.N., Lee, I., Hunziker, W., Zeng, Q., Hong, W., A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells (2008) Cancer Res., 68, pp. 2592-2598
• Etienne-Manneville, S., Polarity proteins in migration and invasion (2008) Oncogene., 27, pp. 6970-6980
• Sahai, E., Marshall, C.J., Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis (2003) Nat Cell Biol., 5, pp. 711-719
• Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Piccolo, S., Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth (2015) Nat Cell Biol., 17, pp. 1218-1227
• Nicolay, B.N., Bayarmagnai, B., Islam, A.B., Lopez-Bigas, N., Frolov, M.V., Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit (2011) Genes Dev., 25, pp. 323-335
• Kapoor, A., Yao, W., Ying, H., Hua, S., Liewen, A., Wang, Q., Zhong, Y., Al-Khalil, R., Yap1 activation enables bypass of oncogenic KRAS addiction in pancreatic cancer (2014) Cell., 158, pp. 185-197
• Fry, D.W., Harvey, P.J., Keller, P.R., Elliott, W.L., Meade, M., Trachet, E., Albassam, M., Toogood, P.L., Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts (2004) Mol Cancer Ther., 3, pp. 1427-1438
• Finn, R.S., Dering, J., Conklin, D., Kalous, O., Cohen, D.J., Desai, A.J., Ginther, C., Slamon, D.J., PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro (2009) Breast Cancer Res., 11, p. R77
• Gelbert, L.M., Cai, S., Lin, X., Sanchez-Martinez, C., Del Prado, M., Lallena, M.J., Torres, R., Chan, E.M., Preclinical characterization of the CDK4/6 inhibitor LY2835219: In-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine (2014) Invest New Drugs., 32, pp. 825-837
• Singh, S., Davis, R., Alamanda, V., Pireddu, R., Pernazza, D., Sebti, S., Lawrence, N., Chellappan, S., Rb-Raf-1 Interaction Disruptor RRD-251 Induces Apoptosis in Metastatic Melanoma Cells and Synergizes with Dacarbazine (2010) Mol Cancer Ther., 9, pp. 3330-3341
• Jézéquel, P., Campone, M., Gouraud, W., Guérin-Charbonnel, C., Leux, C., Ricolleau, G., Campion, L., Bc-GenExMiner: An easy-to-use online platform for gene prognostic analyses in breast cancer (2012) Breast Cancer Res Treat., 131, pp. 765-775
• Jézéquel, P., Frénel, J.S., Campion, L., Guérin-Charbonnel, C., Gouraud, W., Ricolleau, G., Campone, M., bc-GenExMiner 3.0: New mining module computes breast cancer gene expression correlation analyses (2013) Database., 2013
• Bartucci, M., Dattilo, R., Moriconi, C., Pagliuca, A., Mottolese, M., Federici, G., Benedetto, A.D., Patrizii, M., TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells (2014) Oncogene., 34, pp. 1-10
• Ertel, A., Dean, J.L., Rui, H., Liu, C., Witkiewicz, A.K., Knudsen, K.E., Knudsen, E.S., RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response (2010) Cell Cycle., 9, pp. 4153-4163
• Qin, G., Xu, F., Qin, T., Zheng, Q., Shi, D., Xia, W., Tian, Y., Wang, S., Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway (2015) Oncotarget., 6, pp. 41794-41808
• Brocher, J., Vogel, B., Hock, R., HMGA1 downregulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation (2010) BMC Cell Biol., 11, p. 64
• Pegoraro, S., Ros, G., Piazza, S., Sommaggio, R., Ciani, Y., Rosato, A., Sgarra, R., Manfioletti, G., HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness (2013) Oncotarget., 4, pp. 1293-1308
• Shankar, J., Nabi, I.R., RNA purification from tumor cell protrusions using porous polycarbonate filters (2011) Methods Mol Biol., 714, pp. 353-366

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------